Genedata: Powering Biopharma AI

In the age of AI and machine learning, data is more valuable than ever before. However, biopharma companies often lack the high-quality, structured data needed to power advanced models to generate business- and science-accelerating insights. That’s where Genedata comes in. Founded in 1997 by Dr. Othmar Pfannes, Genedata develops scalable enterprise software that produces AI-ready data, ensuring maximum efficiency and ease of collaboration.

Genedata’s philosophy centers on building a high-quality structured data foundation. New robotic systems and laboratory automation are dramatically increasing the amount of experimental data—creating a new need for a truly scalable platform that can structure and manage this exponentially growing volume.  Only with a fully integrated data infrastructure can researchers extract the patterns they need to guide future R&D projects, and this is what Genedata is best-in-class at providing, with solutions covering the entire drug development life cycle. Customers include all top 25 biopharma companies, many innovative biotech organizations, CROs/CDMOs, not-for-profit institutes and academic organizations.

In July 2024, Genedata joined Danaher. By integrating Genedata’s advanced software capabilities and biologics R&D data expertise into our life sciences and diagnostics applications, we are enhancing our internal capabilities and enabling our customers to leverage AI from discovery through manufacturing and commercialization. Ultimately, this integration will accelerate the development of new medicines.